| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $513.7M | -2.2% | +3.0% |
| Cost of Revenue | $414.3M | -1.8% | +2.3% |
| Gross Profit | $99.4M | -4.1% | +6.2% |
| R&D Expense | $5.6M | -16.4% | -1.8% |
| SG&A Expense | $53.7M | -6.1% | -1.1% |
| Operating Income | $16.0M | -20.4% | +128.6% |
| Pre-tax Income | -$5.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $97.1M | +1.6% | -40.1% |
| Accounts Receivable | $200.6M | -4.0% | -3.8% |
| Inventory | $330.3M | -4.1% | -6.8% |
| Current Assets | $672.4M | -4.1% | -13.5% |
| Total Assets | $2.00B | -3.6% | -23.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $114.5M | — | — |
| Capital Expenditures | $28.7M | — | — |
| Investing Cash Flow | -$23.0M | — | — |
| Financing Cash Flow | -$87.8M | — | — |
| Free Cash Flow | $85.8M | — | — |
| -286.7% |
| +76.7% |
| Income Tax | -$2.4M | -119.2% | +25.0% |
| Net Income | -$3.2M | +66.3% | +84.6% |
| EPS (Basic) | -$0.06 | +66.7% | +84.2% |
| EPS (Diluted) | -$0.06 | +66.7% | +84.2% |
| $314.7M |
| +6.5% |
| -4.1% |
| Long-term Debt | $1.05B | -5.7% | -10.0% |
| Total Liabilities | $1.60B | -3.4% | -7.9% |
| Stockholders' Equity | $397.4M | -4.6% | -55.0% |